AmerisourceBergen Corp and private equity firm TPG Inc will buy OneOncology from General Atlantic in a deal valued at $2.1 billion, the companies said on Thursday.
The deal will allow AmerisourceBergen to diversify beyond its large drug distribution business by adding a network of cancer specialists to its portfolio as well as expand its practice management services.
AmerisourceBergen in September struck a $1.3 billion deal to acquire Germany’s PharmaLex, which provides biopharma companies services like clinical development consulting and market authorization.
TPG will buy the majority interest in OneOncology, while AmerisourceBergen will purchase a minority stake for around $685 million in cash.
The OneOncology deal is expected to contribute a few cents to adjusted profit in the first year after close, expected by the end of September, AmerisourceBergen said.
AmerisourceBergen minority stake would represent about 35% ownership in a joint venture to be formed for the acquisition.
The joint venture includes TPG and OneOncology-associated practices, physicians and management team, who would also retain a minority interest.
Source: Reuters.com